Luikart H - Search Results

1

Changing trends in infectious disease in heart transplantation.

Haddad F, Deuse T, Pham M, Khazanie P, Rosso F, Luikart H, Valantine H, Leon S, Vu TA, Hunt SA, Oyer P, Montoya JG. Haddad F, et al. Among authors: luikart h. J Heart Lung Transplant. 2010 Mar;29(3):306-15. doi: 10.1016/j.healun.2009.08.018. Epub 2009 Oct 22. J Heart Lung Transplant. 2010. PMID: 19853478

2

Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.

Kuo PC, Luikart H, Busse-Henry S, Hunt SA, Valantine HA, Stinson EB, Oyer PE, Scandling JD, Alfrey EJ, Dafoe DC. Kuo PC, et al. Among authors: luikart h. Clin Transplant. 1995 Apr;9(2):92-7. Clin Transplant. 1995. PMID: 7599409

3

Characteristics of patients surviving more than ten years after cardiac transplantation.

DeCampli WM, Luikart H, Hunt S, Stinson EB. DeCampli WM, et al. Among authors: luikart h. J Thorac Cardiovasc Surg. 1995 Jun;109(6):1103-14; discussion 1114-5. doi: 10.1016/S0022-5223(95)70194-X. J Thorac Cardiovasc Surg. 1995. PMID: 7776675 Free article.

4

Impact of cyclosporine dose on long-term outcome after heart transplantation.

Valantine H, Hunt S, Gamberg P, Miller J, Luikart H. Valantine H, et al. Among authors: luikart h. Transplant Proc. 1994 Oct;26(5):2710-2. Transplant Proc. 1994. PMID: 7940848 No abstract available.

5

Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life.

Rickenbacher PR, Lewis NP, Valantine HA, Luikart H, Stinson EB, Hunt SA. Rickenbacher PR, et al. Among authors: luikart h. Eur Heart J. 1997 May;18(5):870-8. Eur Heart J. 1997. PMID: 9152659

6

Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone.

Valantine HA, Luikart H, Doyle R, Theodore J, Hunt S, Oyer P, Robbins R, Berry G, Reitz B. Valantine HA, et al. Among authors: luikart h. Transplantation. 2001 Nov 27;72(10):1647-52. doi: 10.1097/00007890-200111270-00012. Transplantation. 2001. PMID: 11726825

7

Efficacy and safety of atorvastatin after pediatric heart transplantation.

Chin C, Gamberg P, Miller J, Luikart H, Bernstein D. Chin C, et al. Among authors: luikart h. J Heart Lung Transplant. 2002 Nov;21(11):1213-7. doi: 10.1016/s1053-2498(02)00455-2. J Heart Lung Transplant. 2002. PMID: 12431495

8

Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience.

Chin C, Naftel DC, Singh TP, Blume ED, Luikart H, Bernstein D, Gamberg P, Kirklin JK, Morrow WR; Pediatric Heart Transplant Study Group. Chin C, et al. Among authors: luikart h. J Heart Lung Transplant. 2004 Feb;23(2):178-85. doi: 10.1016/S1053-2498(03)00059-7. J Heart Lung Transplant. 2004. PMID: 14761765

9

Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab.

Chin C, Pittson S, Luikart H, Bernstein D, Robbins R, Reitz B, Oyer P, Valantine H. Chin C, et al. Among authors: luikart h. Transplantation. 2005 Aug 27;80(4):477-81. doi: 10.1097/01.tp.0000168153.50774.30. Transplantation. 2005. PMID: 16123721 Clinical Trial.

10

Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study.

Fearon WF, Hirohata A, Nakamura M, Luikart H, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Fitzgerald PJ, Yock PG, Yeung AC. Fearon WF, et al. Among authors: luikart h. J Heart Lung Transplant. 2006 Jul;25(7):765-71. doi: 10.1016/j.healun.2006.03.003. Epub 2006 May 24. J Heart Lung Transplant. 2006. PMID: 16818118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page